[AKEI NEWSLETTER 16호]Pharmaceutical and bio trends "CphI Korea/Hi Korea" a…
Page Info
내용
Pharmaceutical
and bio trends "CphI Korea/Hi Korea" at a glance.
An
exhibition was held to check trends in the global pharmaceutical and bio
industries and health industries. There were 81 participating countries from 10
countries, 63 domestic companies participated, and 18 overseas companies
participated.
Various
free conferences were also prepared. A total of 21 presentations were prepared
through five sessions during the three days of the exhibition. Anyone can apply
through the Internet and it was conducted offline and online at the same time.
On
the afternoon of the first day, CAIQTEST Korea General Manager Joo-yeon Kim
attended the 'Strategies for Response to the 2022 Health Food and Food-Related
Import Permit System in China' and the 'Korea-China FTA Preparation Process for
Health Food and Food Industry and Issuance of Certificate of Origin' by Yoo
Dae-hyeok, a customs company in Seoul. Information sharing continued.
On
the second day, under the theme of 'KDRA Innovation Policy Research Center
(InnoPol), the first biohealth policy forum in 2021/plan to support the next
government's development of the biohealth industry to strengthen the global
competitiveness of the biohealth industry,' 'Trends and development tasks of
the biohealth industry SK Biopharmaceuticals Vice President Shin Hae-in's
'Measures to support the global expansion of the domestic biohealth industry'
Cure Therapeutics CEO Kim Tae-ho's 'Advanced biopharmaceutical technology
strategy: First or Best Penguin?' Paminogen CEO Kim Young-hoon's 'A plan to
improve productivity of new drug development using AI/big data' Professor Kwon
Kyung-hee of Dongguk University's College of Pharmacy presented 'A strategy for
advancing licensing regulations'.